Microdosing
Category: Medical · Level: Intermediate
Microdosing refers to the practice of consuming very small, sub-perceptual doses of cannabis to achieve therapeutic benefits without significant psychoactive effects.
Microdosing in cannabis refers to intentionally consuming doses significantly below those required to produce psychoactive effects — typically 1–5mg of THC. This approach is used by patients and consumers seeking symptom relief (pain, anxiety, mood) with minimal impairment. Research suggests that low doses of THC may produce different effects compared to higher doses — a dose-dependent phenomenon sometimes called 'biphasic response.' Microdosing is increasingly used in clinical research settings and has gained popularity in both medical and adult-use markets. It presents challenges for product standardization and labeling.
Also known as
Low-dose cannabis, Threshold dosing
Usage
- Medical
- Recreational
Related terms
- THC — Tetrahydrocannabinol (THC) is the primary psychoactive cannabinoid in cannabis, responsible for the 'high' associated with its use.
- CBD — Cannabidiol (CBD) is a non-psychoactive cannabinoid found in cannabis and hemp, widely used in medical research and consumer wellness products.